以上研究不仅揭开了病原体的新伎俩，还为未来设计“新型抗病作物”提供了灵感！且看马拉加大学的Miguel A. Botella研究团队在Plant cell &Environment上，发表了题为“Hidden in plain sight: ...

Targeting a newly discovered vulnerability in the signals that cyst nematodes use to infect plant roots could be a powerful ...

In a promising new study, scientists have adapted an experimental cancer treatment to control celiac disease. The method ...

eFFECTOR Therapeutics, Inc. SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) today announced that the Company has ...

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

Every living creature on Earth needs to protect itself from things that would do it harm. Bacteria are no different. And ...

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific ...

The research, co-authored by MD/Ph.D. student Samantha "Sammy" Tse-Kang and Read Pukkila-Worley, MD, professor of medicine, uncovered a mechanism of effector-triggered immunity in animals ...

Explore eFFECTOR Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EFTR. Why eFFECTOR Therapeutics (EFTR) Shares Are Down Over 70% EFFECTOR ...

It’s the end of an era—eFFECTOR Therapeutics’ era to be exact. The oncology biotech has laid off staff as it plans to wind down, according to a June 24 company release. This includes ...

Immune effector cell-associated neurotoxicity syndrome (ICANS) is a possible side effect of certain immunotherapies. This condition causes inflammation in the brain, leading to symptoms.